抗发作药物和的突然意外死亡:一个更新的审查
Anemoon T Bosch1, Josemir W Sander1,2,3,4,5, Roland D Thijs6,7,8
1Stichting Epilepsie Instellingen Nederland (SEIN), 2103 SW, Heemstede, The Netherlands.
CNS drugs
|August 7, 2024
概括
中突然意外死亡 (SUDEP) 是一个主要问题. 虽然抗发作药物 (ASM) 有助于控制发作,但它们对超出发作控制的SUDEP风险的直接影响尚不清楚,一些证据表明多疗法可能具有保护作用.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 中突然意外死亡 (SUDEP) 是大多数相关死亡的原因.
- SUDEP通常与无证人的夜间焦点到双边强力-克隆性发作 (TCS) 有关.
- 目前的预防策略是有限的,因为未知的潜在的SUDEP机制.
研究的目的:
- 批判性地评估关于抗发作药物 (ASM),非药物和发作检测装置 (SDD) 如何影响SUDEP发生的证据.
- 探索超出控制范围的潜在干预措施,可能调节SUDEP风险.
主要方法:
- 对现有研究进行系统审查和批判性评估.
- 分析与SUDEP相关的ASM,并发性非药物和发作检测设备的数据.
- 对多疗法和特定药物效应的证据评估.
主要成果:
- 没有强有力的证据表明,启动ASM直接影响超出控制TCS的SUDEP风险.
- 一些迹象表明,ASM多疗可能会对SUDEP产生保护作用.
- 没有特定的ASM被确定增加SUDEP风险; levetiracetam在一项研究中显示了可能的保护作用.
- 关于非药物的证据有限且不一致;在一项研究中,他类药物表明SUDEP风险较低.
- 间接证据支持加强夜间监督,但SDD对SUDEP的直接影响仍未得到充分调查.
结论:
- 需要进一步的研究来了解ASM和其他干预措施如何调节SUDEP风险.
- 在调查SUDEP时,未来的研究应该考虑发作频率,多药性和坚持标记.
- 探索非控制机制对于制定有针对性的SUDEP预防策略至关重要.
更多相关视频
10:25Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
Published on: March 27, 2021
6.0K
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
17.7K
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
152
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
152
01:08Antiepileptic Drugs: Sodium Channel Blockers
472
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
472
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
276
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
276
01:17Antiepileptic Drugs: Calcium Channel Blockers
350
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
350
01:30Electroconvulsive Therapy
29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29
01:14Antiepileptic Drugs: Glutamate Antagonists
303
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
303